showed a trendP = 0.0925
Meanwhile, among patients with [ALB] serum >3.77 g/dl, the NCOA3 high or TM4SF5 high /NCOA3 high groups showed significantly poorer clinical outcomes compared with those of the TM4SF5 low /COA3 low group, and the TM4SF5 high group showed a trend toward a poor clinical outcome (nonsignificant, P = 0.0925; Fig. 8c ).